Answering the first question AML patients ask – how did I get this?

Mark Levis, MD, PhD from The Johns Hopkins University, Baltimore, MD discusses a common question that acute myeloid leukemia (AML) patients ask on their first visit, “how did I get this?”. Today there is a much better understanding of AML and often its cause cannot be pinpointed to a patient’s actions but rather is caused by the natural increase of mutations with age. Recorded at the European Hematology Association (EHA) 2016 Annual Congress in Copenhagen, Denmark.

Share this video  
9th June 2016